44 minutes ago2 minTechnologyuBriGene's Educational Webinar Series on ATMPs Development and ManufacturingEmbark on a journey from ATMPs concept to commercialization with uBriGene's groundbreaking webinar series. As leaders in the development...
2 hours ago2 minCorporateuBriGene's showcase at ISCT2024 Vancouver May 29 - Jun 1We are delighted to announce that uBriGene will exhibit at the International Society for Cell and Gene Therapy (ISCT) 2024 conference. As...
Apr 172 minCorporateuBriGene will exhibit at ASGCT2024 this May 7 – 11 in BaltimoreWe’re excited to share that uBriGene will be participating in ASGCT2024 with an assortment of engaging activities. We will showcase...
Mar 141 minTechnologyNew Service Launch - Cell Therapy Potency Analytical Development and GMP TestingWe at uBriGene Biosciences are excited to launch the new Cell Therapy Potency Analytical Development and GMP Testing service at the...
Feb 21 minTechnologyTop 3 success factors for cell therapy potency assaysDo you know what FDA is looking for in the cell therapy potency assays? FDA published a guideline in Dec 2023 on CGT potency assay. We...
Jul 31, 20231 minCorporateuBriGene (Boston) Biosciences completed the transaction with Mustang Bio, Inc. (Nasdaq: MBIO)uBriGene (Boston) Biosciences Inc. (“uBriGene”), the U.S. subsidiary of uBriGene Group, a leading cell and gene therapy contract...